With the unique properties such as high surface area to volume ratio, stability, inertness, ease of functionalization, as well as novel optical, electrical, and magnetic behaviors, nanomaterials have a wide range of applications in various fields with the common types including nanotubes, dendrimers, quantum dots, and fullerenes. With the aim of providing useful insights to help future development of efficient and commercially viable technology for large-scale production, this review focused on the science and applications of inorganic and organic nanomaterials, emphasizing on their synthesis, processing, characterization, and applications on different fields. The applications of nanomaterials on imaging, cell and gene delivery, biosensor, cancer treatment, therapy, and others were discussed in depth. Last but not least, the future prospects and challenges in nanoscience and nanotechnology were also explored.
IMPORTANCEIvermectin, an inexpensive and widely available antiparasitic drug, is prescribed to treat COVID-19. Evidence-based data to recommend either for or against the use of ivermectin are needed. OBJECTIVE To determine the efficacy of ivermectin in preventing progression to severe disease among high-risk patients with COVID-19. DESIGN, SETTING, AND PARTICIPANTS The Ivermectin Treatment Efficacy in COVID-19 High-Risk Patients (I-TECH) study was an open-label randomized clinical trial conducted at 20 public hospitals and a COVID-19 quarantine center in Malaysia between May 31 and October 25, 2021. Within the first week of patients' symptom onset, the study enrolled patients 50 years and older with laboratory-confirmed COVID-19, comorbidities, and mild to moderate disease. INTERVENTIONS Patients were randomized in a 1:1 ratio to receive either oral ivermectin, 0.4 mg/kg body weight daily for 5 days, plus standard of care (n = 241) or standard of care alone (n = 249). The standard of care consisted of symptomatic therapy and monitoring for signs of early deterioration based on clinical findings, laboratory test results, and chest imaging. MAIN OUTCOMES AND MEASURESThe primary outcome was the proportion of patients who progressed to severe disease, defined as the hypoxic stage requiring supplemental oxygen to maintain pulse oximetry oxygen saturation of 95% or higher. Secondary outcomes of the trial included the rates of mechanical ventilation, intensive care unit admission, 28-day in-hospital mortality, and adverse events. RESULTS Among 490 patients included in the primary analysis (mean [SD] age, 62.5 [8.7] years; 267 women [54.5%]), 52 of 241 patients (21.6%) in the ivermectin group and 43 of 249 patients (17.3%) in the control group progressed to severe disease (relative risk [RR], 1.25; 95% CI, 0.87-1.80; P = .25). For all prespecified secondary outcomes, there were no significant differences between groups. Mechanical ventilation occurred in 4 (1.7%) vs 10 (4.0%) (RR, 0.41; 95% CI, 0.13-1.30; P = .17), intensive care unit admission in 6 (2.4%) vs 8 (3.2%) (RR, 0.78; 95% CI, 0.27-2.20; P = .79), and 28-day in-hospital death in 3 (1.2%) vs 10 (4.0%) (RR, 0.31; 95% CI, 0.09-1.11; P = .09). The most common adverse event reported was diarrhea (14 [5.8%] in the ivermectin group and 4 [1.6%] in the control group). CONCLUSIONS AND RELEVANCEIn this randomized clinical trial of high-risk patients with mild to moderate COVID-19, ivermectin treatment during early illness did not prevent progression to severe disease. The study findings do not support the use of ivermectin for patients with COVID-19.TRIAL REGISTRATION ClinicalTrials.gov Identifier: NCT04920942
The potential of granular-activated carbon (GAC) derived from agrowaste of Mangostene (Mangostana garcinia) fruit peel was investigated in batch and fixed bed system as a replacement of current expensive methods for treating wastewater contaminated by manganese, Mn(II) cations. Batch equilibrium data was analyzed by Langmuir, Freundlich, and Temkin isotherm models at different temperatures. The effect of inlet metal ion concentration (50 mg/L, 70 mg/L, and 100 mg/L), feed flow rate (1 mL/min and 3 mL/min), and activated carbon bed height (4.5 cm and 3 cm) on the breakthrough characteristics of the fixed bed sorption system were determined. The adsorption data were fitted with well-established column models, namely, Thomas, Yoon-Nelson, and Adams-Bohart. The results were best-fitted with Thomas and Yoon-Nelson models rather than Adams-Bohart model for all conditions. The column had been regenerated and reused consecutively for five cycles. The results demonstrated that the prepared activated carbon was suitable for removal of Mn(II) ions from wastewater using batch as well as fixed bed sorption system.
The objective of this study was to explore the influence of pyrolysis temperature on the physicochemical properties of biochar synthesized from durian wood (Durio zibethinus) sawdust. Surface morphological features, including the porosity and BET surface area of biochars, provide appropriate dimensions for growing clusters of microorganisms with excellent water retention capacity in soil. Oxygen-containing surface functional groups play a vital role in improving soil fertility by increasing its cation and anion exchange capacities with reduced leaching of nutrients from the soil surface. Biochar was produced via slow pyrolysis of woody biomass (WS) using a fixed bed reactor under an oxygen-free atmosphere at different pyrolysis temperatures (350, 450, and 550 °C). The biochars obtained were characterized using ultimate and proximate analyses, Brunauer-Emmett-Teller (BET) surface area, field-emission scanning electron microscopy (FE-SEM), Fourier transform infrared spectroscopy (FTIR), and X-ray diffraction (XRD). The yield of biochar decreased from 66.46 to 24.56%, whereas the BET surface area increased sharply from 2.567 to 220.989 m 2 /g, when the pyrolysis temperature was increased from 350 to 550 °C. The results highlighted the effect of pyrolysis temperature on the structure of the biochar, which could be advantageous for agricultural industries.
Background Globally, ~500 000 people with severe dengue (SD) require hospitalization yearly; ~12 500 (2.5%) die. Secondary hemophagocytic lymphohistiocytosis (sHLH) is a potentially fatal hyperinflammatory condition for which HLH-directed therapy (as etoposide and dexamethasone) can be life-saving. Prompted by the high mortality in SD and the increasing awareness that patients with SD may develop sHLH, our objectives were to (1) determine the frequency of dengue-HLH in SD, (2) describe clinical features of dengue-HLH, (3) assess mortality rate in SD and dengue-HLH, and (4) identify mortality-associated risk factors in SD. Methods A 5-year retrospective single-center study in all adult patients with SD admitted to a tertiary intensive care unit in Malaysia. Results Thirty-nine of 180 (22%) patients with SD died. Twenty-one of 180 (12%) had HLH defined as an HLH probability ≥70% according to histo score (HScore); 9 (43%) died. Similarly, 12 of 31 (39%) fulfilling ≥4 and 7 of 9 (78%) fulfilling ≥5 HLH-2004 diagnostic criteria died. Peak values of aspartate aminotransferase (AST), alanine aminotransferase, lactate dehydrogenase, and creatinine correlated to fatality (odds ratios [ORs], 2.9, 3.4, 5.8, and 31.9; all P < .0001), as did peak ferritin (OR, 2.5; P = .0028), nadir platelets (OR, 1.9; P = .00068), hepatomegaly (OR, 2.9; P = .012), and increasing age (OR, 1.2; P = .0043). Multivariable logistic regression revealed peak AST (OR, 2.8; P = .0019), peak creatinine (OR, 7.3; P = .0065), and SOFA (Sequential Organ Failure Assessment) score (OR, 1.4; P = .0051) as independent risk factors of death. Conclusions Be observant of dengue-HLH due to its high mortality. A prospective study is suggested on prompt HLH-directed therapy in SD patients with hyperinflammation and evolving multiorgan failure at risk of developing dengue-HLH.
In this research, activated biochar has been produced by a base catalytic approach for removal of Mn(ii) cations from waste water.
This study focuses on the extraction of cellulose nano-whiskers (CNWs) from the leaves of Adansonia kilima (AK), usually known as African baobab, using a combination of a microwave-assisted alkali (KOH) pre-treatment with subsequent bleaching process prior to ultra-sonication. Ultra-sonication was carried out using the ionic liquid (IL) 1-butyl-3-methylimidazolium hydrogen sulfate (Bmim-HSO4). Process parameters for ultra-sonication were optimized using a two-level factorial Box–Behnken design (BBD). Process variables such as ultra-sonication power (x1), hydrolysing time (x2) and temperature (x3) were varied. Responses selected were percentage crystallinity index, CrI% (y1) and yield% (y1) for the finally procured CNWs sample. Regression analysis was carried out to develop quadratic model to analyze the effect of process variables on IL-assisted ultra-sonication process. Analysis of variance (ANOVA) showed that ultra-sonication power was the most influential aspect for hydrolyzing the amorphous segments of crude cellulose extracted from baobab leaves. A relative study of the physio-chemical properties of the starting lignocellulosic substrate (AK), KOH pre-treated, bleached and IL-assisted ultra-sonicated CNWs was conducted. The synthesized samples were characterized using Fourier transform infrared spectroscopy, Scanning electron microscopy, atomic force microscopy, high resolution transmission electron microscopy, X-ray diffraction and thermo-gravimetric and zeta potential analysis. Under optimum condition, the extracted CNWs showed an average width of 15–20 nm; with high crystallinity index of 86.46%. This research provides an insight about the delignification of Adansonia kilima (AK) leaves and its effective conversion to CNWs having high crystallinity.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.